Kailera Therapeutics, Inc. Common Stock (KLRA) is a publicly traded the market company. As of May 21, 2026, KLRA trades at $20.10 with a market cap of $2.53B and a P/E ratio of 0.00. KLRA moved +2.34% today. Year to date, KLRA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $19.01 to $28.23. Analyst consensus is strong buy with an average price target of $45.00. Rallies surfaces KLRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for KLRA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $20.10 |
| Market Cap | $2.53B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.23 |
| 52-Week Low | $19.01 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover KLRA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.00.